RecruitingRecruiting
QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis
NCT04030676 · Centre Hospitalier Universitaire de Saint Etienne
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
Official title
Place of the QuantiFERON-CMV (QF-CMV) Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis (UC)
About this study
This study aim to evaluate the performances of this new assay to predict the risk of CytoMegaloVirus (CMV) reactivation in the colon of UC patients. A new algorithm for the care of Ulcerative Colitis (UC) patients that could be used in all centers, even those without molecular biology lab, could be proposed: in case of a positive QuantiFERON-CytoMegaloVirus (QF-CMV) assay, the immune response protects the patient against Cytomegalovirus (CMV) reactivation and intensification of immunosuppressive therapies should be proposed; at the opposite, a negative QuantiFERON-CytoMegaloVirus (QF-CMV) assay will invite to biopsy in order to detect CytoMegaloVirus (CMV) replication and to treat with ganciclovir when appropriate. This algorithm will preserve invasive biopsies in absence of CytoMegaloVirus (CMV) tissue reactivation.
Eligibility criteria
Inclusion Criteria:
* Patient with seropositive for CytoMegaloVirus (CMV) (IgG+)
* Patient requiring hospitalization for flare of Ulcerative Colitis (UC) with Mayo score \> 5 and an endoscopic subscore ≥ 2
* Social security affiliation
* Signed informed consent
Exclusion Criteria:
* Wardship patient and curatorial patient
* Patient unable to understand or sign the protocol
* Colectomy total or partial
Study design
Enrollment target: 196 participants
Allocation: na
Masking: none
Age groups: adult, older_adult
Timeline
Starts: 2019-07-17
Estimated completion: 2026-04
Last updated: 2025-04-29
Interventions
Procedure: BiopsiesBiological: Blood samples
Primary outcomes
- • Quantification of CytoMegaloVirus (CMV) DeoxyriboNucleic Acid (DNA) load (quantitative PolymeraseChainReaction (qPCR) analysis) in the inflammatory tissue - UI/100 000 cells (At the inclusion)
- • QuantiFERON-CytoMegaloVirus (QF-CMV) test result (UI/ml) in blood (At the inclusion)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · other
Contacts & investigators
ContactXavier ROBLIN, MD PhD · contact · xavier.roblin@chu-st-etienne.fr · (0)477828119
ContactSylvie PILLET, PhD · contact · sylvie.pillet@chu-st-etienne.fr · (0)477828315
InvestigatorXavier ROBLIN, MD PhD · principal_investigator, Centre Hospitalier Universitaire de Saint Etienne
InvestigatorSylvie PILLET, PhD · study_director, Centre Hospitalier Universitaire de Saint Etienne
All locations (2)
HCL-Hôpital Lyon SudRecruiting
Lyon, France
Chu Saint-EtienneRecruiting
Saint-Etienne, France